Aliskiren/ amlodipine
|
No appropriate data
|
1 (4)
|
Medicine (aliskiren)
|
1 (2)
|
Medicine (aliskiren)
|
Bromfenac
|
No dossier submitted
|
4 (7)
|
Class (NSAID)
|
1 (2)
|
Class (NSAID)
|
Canagliflozin
|
Insufficient clinical superiority
|
1 (4)
|
Class (SGLT-2 inhibitors)
|
3 (3)
|
Medicine (canagliflozin)
|
Canagliflozin/ metformin
|
Insufficient clinical superiority
|
1 (5)
|
Class (SGLT-2 inhibitors/metformin)
|
3 (3)
|
Class (SGLT-2 inhibitors/metformin)
|
Colestilan
|
Insufficient clinical superiority
|
1 (1)
|
Class (phosphate binding agents)
|
1 (1)
|
Class (phosphate binding agents)
|
Gaxilose
|
No dossier submitted
|
n.a.
|
n.a.
|
n.a.
|
n.a.
|
Insulin degludec
|
Insufficient clinical superiority
|
7 (7)
|
Class (basal insulin analogues)
|
3 (3)
|
Medicine (insulin degludec)
|
Living larvae from Lucilia sericata
|
No dossier submitted
|
1 (1)
|
Medicine (living larvae)
|
n.a.
|
n.a.
|
Linaclotide
|
Insufficient clinical superiority
|
0 (4)
|
n.a.
|
1 (1)
|
Medicine (linaclotide)
|
Linagliptin
|
Insufficient clinical superiority
|
2 (3)
|
Class (DPP-4 inhibitors)
|
3 (3)
|
Medicine (linagliptin) and class (DPP-4 inhibitors)
|
Lixisenatide
|
Insufficient clinical superiority
|
5 (5)
|
Class (GLP-1 agonists)
|
3 (4)
|
Medicine (lixisenatide) and class (GLP-1 agonists)
|
Lomitapide
|
Insufficient clinical superiority
|
0 (2)
|
n.a.
|
1 (1)
|
Medicine (lomitapide)
|
Lurasidone
|
Insufficient clinical superiority
|
4 (4)
|
Medicine (lurasidone)
|
2 (2)
|
Class (second generation antipsychotic drugs)
|
Microbial collagenase
|
Insufficient clinical superiority
|
n.a.
|
n.a.
|
n.a.
|
n.a.
|
Mirabegron
|
Insufficient clinical superiority
|
0 (6)
|
n.a.
|
1 (1)
|
Medicine (mirabegron)
|
Perampanel
|
No appropriate data
|
0 (1)
|
n.a.
|
0 (1)
|
n.a.
|
Regorafenib
|
Insufficient clinical superiority
|
0 (7)
|
n.a.
|
3 (6)
|
Medicine (regorafenib)
|
Retigabine
|
No appropriate data
|
1 (1)
|
Medicine (retigabine)
|
1 (1)
|
Medicine (retigabine)
|
Sipuleucel-T
|
n.a.
|
4 (11)
|
Medicine (sipuleucel-T)
|
5 (9)
|
Medicine (sipuleucel-T)
|
Tafluprost/timolol
|
Insufficient clinical superiority
|
2 (2)
|
Class (preservative- free medicines)
|
n.a.
|
n.a.
|
Vildagliptin
|
Insufficient clinical superiority
|
5 (5)
|
Medicine (vildagliptin)
|
4 (4)
|
Medicine (vildagliptin) and class (DPP-4 inhibitor)
|
Vildagliptin/ metformin
|
Insufficient clinical superiority
|
5 (5)
|
Medicine (vildagliptin/metformin)
|
4 (4)
|
Class (DPP-4 inhibitors/metformin)
|